Great result.JGL is now on track with $5.5m in the bank and another profit season looming.In my opinion we should soon see a rerating. The stock should be trading at mid teens at this point in time.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025